US20040018543A1 - Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses - Google Patents
Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses Download PDFInfo
- Publication number
- US20040018543A1 US20040018543A1 US10/618,586 US61858603A US2004018543A1 US 20040018543 A1 US20040018543 A1 US 20040018543A1 US 61858603 A US61858603 A US 61858603A US 2004018543 A1 US2004018543 A1 US 2004018543A1
- Authority
- US
- United States
- Prior art keywords
- groups
- alkyl
- nanotubes
- carbon
- biological macromolecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 C*(COCC*=C)COP(O)(OCC(C)(C)COCC(C*=C)N)=O Chemical compound C*(COCC*=C)COP(O)(OCC(C)(C)COCC(C*=C)N)=O 0.000 description 8
- RNZDFWSUYFNWOV-UHFFFAOYSA-N CCC.CCCOCCC.CCCOCCOP(=O)(O)OCCOCCC Chemical compound CCC.CCCOCCC.CCCOCCOP(=O)(O)OCCOCCC RNZDFWSUYFNWOV-UHFFFAOYSA-N 0.000 description 4
- MOFXVRSCSHLZFP-WLCURHLYSA-N NCCOCCOCCNC(=O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.O=C(O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.[H]C(CCCCNC(=O)CC1C2=C(C3=C(C=CC=C3)C3=CC=CC=C32)C2=C1C1=CC=CC=C1C1=C2C=CC=C1)(C(=O)O)N(CC(=O)O)CC(=O)O.[H]C1([H])S[C@@H](CCCCC(=O)NCCOCCOCCNC(=O)COCC2=C3/C=C\C=C/C3=CC3=C2C=CC=C3)[C@H]2NC(=O)N[C@H]21 Chemical compound NCCOCCOCCNC(=O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.O=C(O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.[H]C(CCCCNC(=O)CC1C2=C(C3=C(C=CC=C3)C3=CC=CC=C32)C2=C1C1=CC=CC=C1C1=C2C=CC=C1)(C(=O)O)N(CC(=O)O)CC(=O)O.[H]C1([H])S[C@@H](CCCCC(=O)NCCOCCOCCNC(=O)COCC2=C3/C=C\C=C/C3=CC3=C2C=CC=C3)[C@H]2NC(=O)N[C@H]21 MOFXVRSCSHLZFP-WLCURHLYSA-N 0.000 description 2
- HEZFWMJOBBWNOH-UHFFFAOYSA-N O=C(COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2)ON1C(=O)CCC1=O Chemical compound O=C(COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2)ON1C(=O)CCC1=O HEZFWMJOBBWNOH-UHFFFAOYSA-N 0.000 description 2
- KUQQERYGHQCVDK-UHFFFAOYSA-N O=C(O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2 Chemical compound O=C(O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2 KUQQERYGHQCVDK-UHFFFAOYSA-N 0.000 description 2
- LLZZJHMYFMQOFP-YDAWOIOESA-N COCCN.NCCOCCOCCNC(=O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.O=C(COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2)ON1C(=O)CCC1=O.O=C(O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.OCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.[H]C1([H])SC(CCCCC(=O)NCCOCCOCCNC(=O)COCC2=C3/C=C\C=C/C3=CC3=C2C=CC=C3)C2NC(=O)N[C@H]21 Chemical compound COCCN.NCCOCCOCCNC(=O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.O=C(COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2)ON1C(=O)CCC1=O.O=C(O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.OCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2.[H]C1([H])SC(CCCCC(=O)NCCOCCOCCNC(=O)COCC2=C3/C=C\C=C/C3=CC3=C2C=CC=C3)C2NC(=O)N[C@H]21 LLZZJHMYFMQOFP-YDAWOIOESA-N 0.000 description 1
- WSUFQPUYUZXWNO-UHFFFAOYSA-N NCCOCCOCCNC(=O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2 Chemical compound NCCOCCOCCNC(=O)COCC1=C2/C=C\C=C/C2=CC2=C1C=CC=C2 WSUFQPUYUZXWNO-UHFFFAOYSA-N 0.000 description 1
- IMOBYYAEXHDVCG-UHFFFAOYSA-N [H]C(CCCCNC(=O)CC1C2=C(C3=C(C=CC=C3)C3=CC=CC=C32)C2=C1C1=CC=CC=C1C1=C2C=CC=C1)(C(=O)O)N(CC(=O)O)CC(=O)O Chemical compound [H]C(CCCCNC(=O)CC1C2=C(C3=C(C=CC=C3)C3=CC=CC=C32)C2=C1C1=CC=CC=C1C1=C2C=CC=C1)(C(=O)O)N(CC(=O)O)CC(=O)O IMOBYYAEXHDVCG-UHFFFAOYSA-N 0.000 description 1
- UJIHPKPNOFKRSA-OLWNVYNHSA-N [H]C1([H])S[C@@H](CCCCC(=O)NCCOCCOCCNC(=O)COCC2=C3/C=C\C=C/C3=CC3=C2C=CC=C3)[C@H]2NC(=O)N[C@H]21 Chemical compound [H]C1([H])S[C@@H](CCCCC(=O)NCCOCCOCCNC(=O)COCC2=C3/C=C\C=C/C3=CC3=C2C=CC=C3)[C@H]2NC(=O)N[C@H]21 UJIHPKPNOFKRSA-OLWNVYNHSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic System
- C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic System without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/04—Nickel compounds
- C07F15/045—Nickel compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
- C30B29/58—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/54—Ortho- or ortho- and peri-condensed systems containing more than five condensed rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/724—Devices having flexible or movable element
- Y10S977/727—Devices having flexible or movable element formed from biological material
- Y10S977/729—From protein or unit thereof, e.g. enzyme or carboxyl group
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
- Y10S977/742—Carbon nanotubes, CNTs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
- Y10S977/742—Carbon nanotubes, CNTs
- Y10S977/745—Carbon nanotubes, CNTs having a modified surface
- Y10S977/746—Modified with biological, organic, or hydrocarbon material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
- Y10S977/742—Carbon nanotubes, CNTs
- Y10S977/745—Carbon nanotubes, CNTs having a modified surface
- Y10S977/746—Modified with biological, organic, or hydrocarbon material
- Y10S977/747—Modified with an enzyme
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/789—Of specified organic or carbon-based composition in array format
- Y10S977/79—Of specified organic or carbon-based composition in array format with heterogeneous nanostructures
- Y10S977/791—Molecular array
- Y10S977/793—Protein array
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/842—Manufacture, treatment, or detection of nanostructure for carbon nanotubes or fullerenes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/842—Manufacture, treatment, or detection of nanostructure for carbon nanotubes or fullerenes
- Y10S977/848—Tube end modifications, e.g. capping, joining, splicing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/894—Manufacture, treatment, or detection of nanostructure having step or means utilizing biological growth
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/895—Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
- Y10S977/896—Chemical synthesis, e.g. chemical bonding or breaking
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/895—Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
- Y10S977/896—Chemical synthesis, e.g. chemical bonding or breaking
- Y10S977/898—Enzymatic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/92—Detection of biochemical
Definitions
- the present invention relates to a method of attaching and/or crystallizing macromolecules, to the chemical reagents used in the said method, to the products obtained as well as to the applications of the said products in the field of materials and of structural biology, in particular as biosensors or as biomaterials.
- This method consists in creating a lipid monolayer at the level of an air/liquid interface, the lipids being selected so as to interact with the proteins, present in the liquid phase, which attach to the lipids and then form an organized network.
- the attachment of the proteins to the lipids of the monolayer involves chemical interactions at the level of the polar head of the lipids. These interactions are either aspecific, the lipids possessing charged polar ends, giving rise to crystallization through ionic interactions, or specific. In the latter case, the polar head of the lipids carries ligands exhibiting high affinity with the proteins to be attached.
- lipids functionalized by metal complexes such as nickel complexes
- metal complexes such as nickel complexes
- nickel complexes have made it possible to crystallize so-called histidine tagged fusion proteins.
- These proteins indeed possess, at their N- or C-terminal end, a sequence composed of several histidines. It has been possible to show that the attachment of such proteins to a lipid-nickel was due to a strong interaction between the nickel complex and the poly-histidine sequence (C. Vommeen-Brian et al., J. Mol. Biol., 1997, 274, 687-692).
- Such functionalized lipids have made it possible to obtain crystallization, in particular in the case where an appropriate ligand was not available.
- the ligand carried by the lipids should be sufficiently accessible in order to be able to interact with the proteins. This accessibility depends on the length of the spacer arm between the lipid and the ligand: too short, it gives rise to a penetration of the protein inside the lipid layer; too long, it confers an extremely high degree of freedom on the bound protein and increases the incidence of defects in the crystal;
- the lipid monolayer should be sufficiently fluid in order to confer a sufficient lateral and rotational mobility on the bound protein, thus allowing the proteins to organize relative to each other and to develop intermolecular contacts, so as to give rise to the crystal;
- the subject of the present invention is a method for the attachment and/or self-organization of biological macromolecules, characterized in that it essentially comprises the incubation, without stirring, for at least 15 minutes, of a macromolecule in solution with nanotubes of carbon closed at their ends, under suitable temperature and pH conditions.
- Nanotubes were discovered in 1991 (S. Ijima, Nature 1991, 354, 54-56); since then, they have generated a lot of interest, in particular because of their mechanical properties: high mechanical resistance (M. M. J. Treacy et al., Nature 1996, 381, pp. 678-680) and electronic properties: conductor or semiconductor property (J. W. G. Wildöer et al., Nature 1998, 391, 59-62: T. W. Odom et al., Nature, 1998, 391, 62-64).
- Nanotubes modified by such destructive methods are not therefore suitable for adsorption and/or self-organization at their outer surface of synthetic products or of biological macromolecules.
- the nanotubes have in particular so-called multi-wall nanotube structures (MWNT) or single-wall nanotube structures (SWNT) of graphite. They can be completely, partially or not at all oxidized.
- MWNT multi-wall nanotube structures
- SWNT single-wall nanotube structures
- the nanotubes are, from a chemical point of view, polymers composed solely of carbon and which may comprise up to a million atoms.
- the atoms of a nanotube are linked via a solid covalent bond and each atom possesses exactly three neighbours.
- a nanotube is obliged to close at its ends, so as not to leave any chemical bond alone there.
- its diameter is generally between 1 and 30 nm and its length may be up to several micrometres.
- nanotubes can be defined as carbon crystals extending in a single direction, the repeating unit having the symmetry of a helix (B. I. Yakobson et al., American Scientist, 1997, 85, 324-337).
- the said biological macromolecules are in particular soluble, membrane or transmembrane proteins, enzymes, antibodies, antibody fragments or nucleic acids.
- the said nanotubes of carbon are functionalized by physical adsorption of a chemical reagent of general formula H—E—L, in which:
- H represents a hydrophilic group, selected from the positively or negatively charged groups; ligands or analogues of biological macromolecules, such as, without limitation, biotin, novobiocin, retinoic acid, steroids, antigens; organometallic complexes interacting with amino acids or nucleic acids, such as complexes of copper, zinc, nickel, cobalt, chromium, platinum, palladium, iron, ruthenium or osmium with ligands such as IDA, NTA, EDTA, bipyridine or terpyridine, the said ligands being optionally functionalized with alkyl groups for bonding to E (at the level of X); positively or negatively charged groups are understood to mean, without limitation: ammoniums, carboxides, phosphates, sulphonates; the following groups may be mentioned for example: —N(CH 3 ) 3 + or —CO 2 —.
- E represents a spacer arm, selected from C 1 -C 10 carbon chains, optionally substituted with alkyl groups or otherwise, having unsaturations or polyoxyethylene units which may have or otherwise in the middle of the chain phosphate groups, such as:
- m represents an integer from 1 to 10
- X represents O, NHCO, OCO, COO, CONH, S, CH 2 or NH and constitutes, at the ends of the said carbon chains, organic functions for adhesion of the ester, amide, ether or thioether type;
- L represents a lipid unit with one or more chains of variable length, in the form of C 12 -C 20 having unsaturations or otherwise; an aromatic group of formula Ar 1 or of formula Ar 2 :
- A represents a hydrogen atom, one of the following groups: alkyl, CF 3 , NO 2 , NH 2 , OH, O-alkyl, S-alkyl, COOH, halogen, an aromatic ring or an aromatic heterocycle in the form of C 4 -C 6 , optionally polysubstituted with electron-donating groups of the alkyl type or electron-attracting groups of the CF 3 or halide type;
- L represents for example one of the following aromatic groups: benzyl, naphthyl, anthracenyl, fluoroenyl, tetrabenzofluoroenyl, and
- Y represents a bond with E.
- alkyl is understood to mean linear or branched or optionally substituted C 1 -C 6 alkyl groups.
- the functionalization according to the present invention is, surprisingly, non-destructive for the nanotubes; in particular, it avoids the opening of their ends.
- the present invention makes it possible to induce the formation of arrangements of macromolecules (self-organization) such as proteins, with a helical symmetry.
- the said solution consists of a solvent for solubilizing the said biological macromolecules, which is aqueous or aqueous-alcoholic and which optionally contains at least one detergent, depending on the biological macromolecule to be crystallized.
- the incubation conditions are preferably the following: incubation at room temperature, for 15 minutes to 48 hours, at a pH of between 5.5 and 8.5.
- the said method makes it possible to obtain arrangements of biological macromolecules which allow structural studies by electronic microscopy and the preparation of novel nano materials which can be used for their physical, electrical or biological properties.
- Such a method has the advantage of making the crystallization of proteins reproducible; in particular, it is easy, in the case where a protein does not crystallize in the presence of nanotubes of a given diameter, to use the method with nanotubes of different diameter; indeed, the crystallization of a given protein depends on the diameter of the nanotubes.
- the attachment or the crystallization of macromolecules on the nanotubes of carbon may be, under the appropriate experimental conditions, as defined above, either spontaneous, that is to say in the absence of any other synthetic products, or induced by addition of a chemical reagent H—E—L, as defined above.
- the subject of the present invention is also bionanomaterials, characterized in that they essentially consist of nanotubes of carbon, on which biological macromolecules are attached by means of non-covalent bonds.
- the subject of the present invention is also bionanomaterials, characterized in that they essentially consist of nanotubes of carbon, on which biological macromolecules are self-organized in a crystalline form.
- bionanomaterials they are obtained with the aid of a method as defined above.
- the subject of the present invention is in addition the applications of the said bionanomaterials to the structural study of the biological macromolecules which are associated with them, as biological reagent and more particularly as immunological reagent and as biosensors or bioconductors.
- the subject of the present invention is in addition a chemical reagent capable of being physically adsorbed on nanotubes of carbon, characterized in that it has the general formula H—E—L, in which:
- H represents a hydrophilic group selected from the positively or negatively charged groups; ligands or analogues of biological macromolecules; organometallic complexes interacting with amino acids or nucleic acids and whose ligands are optionally functionalized with alkyl groups for bonding to E;
- E represents a spacer arm, selected from C 1 -C 10 carbon chains, optionally substituted with alkyl groups, having unsaturations or otherwise or polyoxyethylene units which may have or otherwise in the middle of the chain phosphate groups, such as:
- m represents an integer from 1 to 10
- X represents O, NHCO, OCO, COO, CONH, S, CH 2 or NH and constitutes, at the ends of the said carbon chains, organic functions for adhesions of the ester, amide, ether or thioether type;
- L represents an aromatic group of formula Ar 1 or of formula Ar 2 :
- A represents a hydrogen atom, one of the following groups: alkyl, CF 3 , NO 2 , NH 2 , OH, O-alkyl, S-alkyl, COOH, halogen, an aromatic ring or an aromatic heterocycle in the form of C 4 -C 6 , the said rings being optionally polysubstituted with electron-donating groups of the alkyl type or electron-attracting groups of the CF 3 or halide type; and
- Y represents a bond with E.
- H is selected from the following organometallic complexes:
- R 1 organic group for bonding to E.
- FIG. 1 illustrates the crystallization of a biological macromolecule on a nanotube of carbon, by addition (physical adsorption) of a chemical reagent
- FIG. 2 illustrates a structure of a chemical reagent used to functionalize, by physical adsorption, the nanotubes of carbon
- FIG. 3 represents nanotubes with a diameter of close to 10 nm, covered with helical crystals of streptavidin;
- FIG. 4 represents nanotubes covered with helical crystals of HupR protein.
- the multi-wall nanotubes of carbon (MWNT) used are produced by decomposition of a graphite electrode with an electric arc (T. W. Ebbesen et al., Nature 1992, Vol. 358, pp. 220-222). After sonication of a solution (2 mg/ml) of nanotubes of carbon, 20 ⁇ g of MWNT are collected and dried with an ethane gas stream so as to be finally resuspended in 20 ⁇ l of a water/methanol mixture (40% of methanol by volume).
- TLC Rf (EtOAc/Hex/AcOH; 80/20/1): 0.56;
- TLC Rf (EtOAc/Hex; 50/50): 0.33;
- TLC Rf (CH 2 Cl 2 /MeOH/TEA; 90/10/1): 0.28;
- TLC Rf (CH 2 Cl 2 /MeOH; 90/10): 0.5;
- Protocol 1 to 20 ⁇ l of a solution of chemical reagent called CR174 and whose chemical formula is illustrated below, (1 mg/ml) in methanol are added to 20 ⁇ l of a solution of nanotubes of carbon (10 mg/ml in methanol), freshly sonicated. The mixture is then stirred by sonication and then evaporated to dryness by a stream of ethane gas. 40 ⁇ l of Tris buffer (20 mM, pH 7.5; 50 mM NaCl) are added to the dry nanotubes of carbon and the suspension is remixed by sonication. The suspension may be optionally centrifuged and washed several times with 500 ⁇ l of buffer in order to remove the excess reagent not adsorbed on the nanotubes of carbon.
- Tris buffer (20 mM, pH 7.5; 50 mM NaCl
Abstract
Method for the attachment and/or crystallization of macromolecules, chemical reagents used in the said method, products obtained as well as applications of the said products in the field of materials and of structural biology, in particular as biosensors or as biomaterials.
The said method comprises essentially the incubation, without stirring, for at least 15 minutes, of a biological macromolecule in solution with nanotubes of carbon closed at their ends, under suitable temperature and pH conditions.
Description
- The present invention relates to a method of attaching and/or crystallizing macromolecules, to the chemical reagents used in the said method, to the products obtained as well as to the applications of the said products in the field of materials and of structural biology, in particular as biosensors or as biomaterials.
- The knowledge of the structure of proteins and in particular of their active sites is essential for understanding their mechanism of action. Several methods are available for carrying out such studies: X-rays, NMR, electrocrystalography (2D crystallization).
- For carrying out the crystallization proper, the technique of two-dimensional crystallization on a lipid film or monolayer, at the air/water interface (E. E. Ugziris et al., Nature, 1983, 301, 125-129), allows the formation of self-organized systems of biological macromolecules (crystals) and the determination of the structures of these molecules by electron microscopy analysis of the crystals obtained.
- This method consists in creating a lipid monolayer at the level of an air/liquid interface, the lipids being selected so as to interact with the proteins, present in the liquid phase, which attach to the lipids and then form an organized network.
- The attachment of the proteins to the lipids of the monolayer involves chemical interactions at the level of the polar head of the lipids. These interactions are either aspecific, the lipids possessing charged polar ends, giving rise to crystallization through ionic interactions, or specific. In the latter case, the polar head of the lipids carries ligands exhibiting high affinity with the proteins to be attached.
- In particular, it has been possible to show that soluble proteins can two-dimensionally crystallize on lipid films which are charged, or which are functionalized by a ligand for the protein studied (B. J. Jap et al., Ultramicroscopy, 1992, 46, 45-84).
- More recently, lipids functionalized by metal complexes such as nickel complexes (E. W. Kubalek et al., J. Struct. Biol., 1994, 113, 117-123) have made it possible to crystallize so-called histidine tagged fusion proteins. These proteins indeed possess, at their N- or C-terminal end, a sequence composed of several histidines. It has been possible to show that the attachment of such proteins to a lipid-nickel was due to a strong interaction between the nickel complex and the poly-histidine sequence (C. Vénien-Brian et al., J. Mol. Biol., 1997, 274, 687-692). Such functionalized lipids have made it possible to obtain crystallization, in particular in the case where an appropriate ligand was not available.
- However, the crystallization of proteins on lipid films has the disadvantage of being relatively random and of depending on many factors, which are difficult to control simultaneously:
- the ligand carried by the lipids should be sufficiently accessible in order to be able to interact with the proteins. This accessibility depends on the length of the spacer arm between the lipid and the ligand: too short, it gives rise to a penetration of the protein inside the lipid layer; too long, it confers an extremely high degree of freedom on the bound protein and increases the incidence of defects in the crystal;
- the lipid monolayer should be sufficiently fluid in order to confer a sufficient lateral and rotational mobility on the bound protein, thus allowing the proteins to organize relative to each other and to develop intermolecular contacts, so as to give rise to the crystal;
- another difficulty, inherent to crystallization on a lipid monolayer, relates to the stability of the monolayer; indeed, the stability of the air/liquid interface is difficult to control. In addition, the lipid monolayer should remain stable, not only before the attachment of the proteins, but also after their attachment, in order to allow the spatial organization of the proteins;
- for the microscopy study which follows the crystallization step, it is necessary to produce a multitude of planes, because of the planar nature of the structure obtained.
- Consequently, the inventors set themselves the aim of providing a method which makes it possible to attach in solution and to optionally induce self-organization of macromolecules which is more suitable for the requirements of practical use than the 2D crystallization methods previously used.
- The subject of the present invention is a method for the attachment and/or self-organization of biological macromolecules, characterized in that it essentially comprises the incubation, without stirring, for at least 15 minutes, of a macromolecule in solution with nanotubes of carbon closed at their ends, under suitable temperature and pH conditions.
- Nanotubes were discovered in 1991 (S. Ijima,Nature 1991, 354, 54-56); since then, they have generated a lot of interest, in particular because of their mechanical properties: high mechanical resistance (M. M. J. Treacy et al., Nature 1996, 381, pp. 678-680) and electronic properties: conductor or semiconductor property (J. W. G. Wildöer et al., Nature 1998, 391, 59-62: T. W. Odom et al., Nature, 1998, 391, 62-64).
- Several methods of preparing nanotubes have been described, including that by T. W. Ebbesen et al. (Nature, 1992, 358, 220-222), which makes it possible to obtain a high yield. Methods of purifying nanotubes have also been described (H. Hiura et al., Adv. Mater., 1995, 7, 275-276; J-M Bonard et al., Adv. Mater., 1997, 9, 827-831 and G. S. Duesberg et al., Chem. Commun. 1998, 435-436); these various methods make it possible to obtain the desired quantities of nanotubes. Methods for the chemical functionalization of nanotubes of carbon have also been described (International Application PCT WO97/32571).
- Other methods for the chemical functionalization of nanotubes have also been described; there may be mentioned for example TSANG S. C. et al.,Journal of the Chemical Society, Chemical Communications, 1995, 17, 1803-1804 and DAVIS J. J. et al., Inorganica Chimica Acta, 1998, 272, 1, 2, 262-266.
- However, they involve chemical reactions which either dramatically modify the geometry of the nanotubes (opening of the ends, partial destruction of the outer sheets), or destroy the intrinsic physical properties of the nanotubes and consequently do not allow organization of biological macromolcules such as proteins, on the nanotubes. Nanotubes modified by such destructive methods are not therefore suitable for adsorption and/or self-organization at their outer surface of synthetic products or of biological macromolecules.
- Depending on the technique and the conditions used, several structures of nanotubes may be prepared: the nanotubes have in particular so-called multi-wall nanotube structures (MWNT) or single-wall nanotube structures (SWNT) of graphite. They can be completely, partially or not at all oxidized.
- Thus, the nanotubes are, from a chemical point of view, polymers composed solely of carbon and which may comprise up to a million atoms. In accordance with the laws of the chemistry of carbon, the atoms of a nanotube are linked via a solid covalent bond and each atom possesses exactly three neighbours. Thus, regardless of its length, a nanotube is obliged to close at its ends, so as not to leave any chemical bond alone there. In general, its diameter is generally between 1 and 30 nm and its length may be up to several micrometres.
- From a physical point of view, nanotubes can be defined as carbon crystals extending in a single direction, the repeating unit having the symmetry of a helix (B. I. Yakobson et al., American Scientist, 1997, 85, 324-337).
- According to an advantageous embodiment of the said method, the said biological macromolecules are in particular soluble, membrane or transmembrane proteins, enzymes, antibodies, antibody fragments or nucleic acids.
- According to another advantageous embodiment of the said method, the said nanotubes of carbon are functionalized by physical adsorption of a chemical reagent of general formula H—E—L, in which:
- H represents a hydrophilic group, selected from the positively or negatively charged groups; ligands or analogues of biological macromolecules, such as, without limitation, biotin, novobiocin, retinoic acid, steroids, antigens; organometallic complexes interacting with amino acids or nucleic acids, such as complexes of copper, zinc, nickel, cobalt, chromium, platinum, palladium, iron, ruthenium or osmium with ligands such as IDA, NTA, EDTA, bipyridine or terpyridine, the said ligands being optionally functionalized with alkyl groups for bonding to E (at the level of X); positively or negatively charged groups are understood to mean, without limitation: ammoniums, carboxides, phosphates, sulphonates; the following groups may be mentioned for example: —N(CH3)3 + or —CO2—.
-
- in which:
- m represents an integer from 1 to 10,
- X represents O, NHCO, OCO, COO, CONH, S, CH2 or NH and constitutes, at the ends of the said carbon chains, organic functions for adhesion of the ester, amide, ether or thioether type;
-
- in which:
- A represents a hydrogen atom, one of the following groups: alkyl, CF3, NO2, NH2, OH, O-alkyl, S-alkyl, COOH, halogen, an aromatic ring or an aromatic heterocycle in the form of C4-C6, optionally polysubstituted with electron-donating groups of the alkyl type or electron-attracting groups of the CF3 or halide type; L represents for example one of the following aromatic groups: benzyl, naphthyl, anthracenyl, fluoroenyl, tetrabenzofluoroenyl, and
- Y represents a bond with E.
- For the purposes of the present invention, alkyl is understood to mean linear or branched or optionally substituted C1-C6 alkyl groups.
- Surprisingly, both untreated (non-functionalized) nanotubes of carbon and nanotubes of carbon functionalized by non-destructive methods, as defined above, can be used in the method according to the invention.
- The functionalization according to the present invention is, surprisingly, non-destructive for the nanotubes; in particular, it avoids the opening of their ends.
- It is possible with such a method to adsorb and/or to self-organize at the outer surface of the nanotubes of carbon either synthetic products or biological macromolecules.
- Indeed, the present invention makes it possible to induce the formation of arrangements of macromolecules (self-organization) such as proteins, with a helical symmetry.
- According to another embodiment of the said method, the said solution consists of a solvent for solubilizing the said biological macromolecules, which is aqueous or aqueous-alcoholic and which optionally contains at least one detergent, depending on the biological macromolecule to be crystallized.
- According to another advantageous embodiment of the said method, the incubation conditions are preferably the following: incubation at room temperature, for 15 minutes to 48 hours, at a pH of between 5.5 and 8.5.
- Surprisingly, the said method makes it possible to obtain arrangements of biological macromolecules which allow structural studies by electronic microscopy and the preparation of novel nano materials which can be used for their physical, electrical or biological properties.
- Such a method has the advantage of making the crystallization of proteins reproducible; in particular, it is easy, in the case where a protein does not crystallize in the presence of nanotubes of a given diameter, to use the method with nanotubes of different diameter; indeed, the crystallization of a given protein depends on the diameter of the nanotubes.
- However, in the present invention, it is possible to vary the diameter of the nanotubes and to use equally well multi-wall or single-wall nanotubes of carbon which are completely, partially or not at all oxidized.
- Also surprisingly, in the method according to the invention, the attachment or the crystallization of macromolecules on the nanotubes of carbon may be, under the appropriate experimental conditions, as defined above, either spontaneous, that is to say in the absence of any other synthetic products, or induced by addition of a chemical reagent H—E—L, as defined above.
- Also surprisingly, the various factors which may come into play in order to allow a reproducible crystallization are, as already specified above, the following: the concentration of the samples, the choice of the solvents, the ionic restraint, the pH of the solutions, the incubation time and the diameter of the nanotubes.
- Both the reagents in which L represents a lipid unit with one or more chains of variable length in the form of C12-C20, having unsaturations or otherwise, and the reagents in which L represents an aromatic group of formula Ar1 or of formula Ar2, make it possible to obtain functionalized nanotubes suitable for the arrangement of macromolecules at their surface; however, the reagents in which L represents an aromatic group of formula Ar1 or of formula Ar2 are particularly preferred.
- The subject of the present invention is also bionanomaterials, characterized in that they essentially consist of nanotubes of carbon, on which biological macromolecules are attached by means of non-covalent bonds.
- The subject of the present invention is also bionanomaterials, characterized in that they essentially consist of nanotubes of carbon, on which biological macromolecules are self-organized in a crystalline form.
- According to an advantageous embodiment of the said bionanomaterials, they are obtained with the aid of a method as defined above.
- The subject of the present invention is in addition the applications of the said bionanomaterials to the structural study of the biological macromolecules which are associated with them, as biological reagent and more particularly as immunological reagent and as biosensors or bioconductors.
- The subject of the present invention is in addition a chemical reagent capable of being physically adsorbed on nanotubes of carbon, characterized in that it has the general formula H—E—L, in which:
- H represents a hydrophilic group selected from the positively or negatively charged groups; ligands or analogues of biological macromolecules; organometallic complexes interacting with amino acids or nucleic acids and whose ligands are optionally functionalized with alkyl groups for bonding to E;
-
- in which:
- m represents an integer from 1 to 10,
- X represents O, NHCO, OCO, COO, CONH, S, CH2 or NH and constitutes, at the ends of the said carbon chains, organic functions for adhesions of the ester, amide, ether or thioether type;
-
- in which:
- A represents a hydrogen atom, one of the following groups: alkyl, CF3, NO2, NH2, OH, O-alkyl, S-alkyl, COOH, halogen, an aromatic ring or an aromatic heterocycle in the form of C4-C6, the said rings being optionally polysubstituted with electron-donating groups of the alkyl type or electron-attracting groups of the CF3 or halide type; and
- Y represents a bond with E.
-
-
- with R1=organic group for bonding to E.
- In addition to the preceding arrangements, the invention further comprises other arrangements, which will emerge from the description which follows, which refer to exemplary embodiments of the method which is the subject of the present invention as well as to the accompanying drawings, in which:
- FIG. 1 illustrates the crystallization of a biological macromolecule on a nanotube of carbon, by addition (physical adsorption) of a chemical reagent;
- FIG. 2 illustrates a structure of a chemical reagent used to functionalize, by physical adsorption, the nanotubes of carbon;
- FIG. 3 represents nanotubes with a diameter of close to 10 nm, covered with helical crystals of streptavidin;
- FIG. 4 represents nanotubes covered with helical crystals of HupR protein.
- It should be clearly understood, however, that these examples are given solely by way of illustration of the subject of the invention and do not constitute in any manner a limitation thereto.
- The multi-wall nanotubes of carbon (MWNT) used are produced by decomposition of a graphite electrode with an electric arc (T. W. Ebbesen et al.,Nature 1992, Vol. 358, pp. 220-222). After sonication of a solution (2 mg/ml) of nanotubes of carbon, 20 μg of MWNT are collected and dried with an ethane gas stream so as to be finally resuspended in 20 μl of a water/methanol mixture (40% of methanol by volume). After sonication, 20 μl of an aqueous solution of streptavidin (10 μg/ml) are added and the mixture is left, without stirring or vortexing, at room temperature for 45 minutes. 5 μl of the suspension of nanotubes of carbon are then deposited on an electron microscopy grid coated with a carbon film. After negative staining of the sample with a solution of uranyl acetate, the grid is observed in an electron microscope (Philips CM120). It was possible to confirm that the nanotubes with a diameter of close to 10 nm are coated with helical crystals of streptavidin.
- The multi-wall nanotubes of carbon (MWNT) used are produced by decomposition of a graphite electrode with an electric arc (T. W. Ebbesen et al.,Nature 1992, Vol. 358, pp. 220-222). After sonication of a solution (2 mg/ml) of nanotubes of carbon, 20 μg of MWNT are collected and dried with an ethane gas stream so as to be finally resuspended in 20 μl of aqueous buffer (10 mM Tris; pH=7.5; 350 mM NaCl). After sonication, 20 μl of an aqueous solution of histidine-tagged HupR protein (10 μg/ml) from Rhodobacter Capsulatus are added and the mixture is left, without stirring or vortexing, at room temperature for 25 minutes. 5 μl of the suspension of nanotubes of carbon are then deposited on an electron microscopy grid coated with a carbon film. After negative staining of the sample with a solution of uranyl acetate, the grid is observed in an electron microscope (Philips CM120). It was possible to note that a large number of nanotubes are coated with helical crystals of HupR protein.
-
- Procedure
- 2.1 g (10 mmol, 1 eq) of 9-anthracenemethanol in 20 ml of THF are added at 0° C. to a suspension of 1.2 g (30 mmol, 3 eq) of sodium hydride at 60% in oil in 20 ml of THF. The mixture is stirred for one hour under reflux and then the temperature is reduced to 0° C. in order to add 1.4 g (10 mmol, 1 eq) of bromoacetic acid in solution in 20 ml of THF. This solution is further stirred for 5 minutes at 0° C. and then for one hour at room temperature before being heated under reflux for 16 hours. After cooling, the reaction is stopped by addition of 40 ml of a saturated aqueous ammonium chloride solution followed by 10 ml of an aqueous hydrochloric acid solution. The reaction medium is then extracted with twice 50 ml of ether. After drying over sodium sulphate, the organic phase is evaporated to dryness in order to give after chromatography on silica (hexane/EtOAc/AcOH: 70/30/1) 1.212 g of a yellow solid (yield: 45.5%).
- EF: C17H14O3 m.p.: 266.299 g/mol
- TLC: Rf (EtOAc/Hex/AcOH; 80/20/1): 0.56;
-
-
- MS (70 eV/DCI/intensity %): m/e: 191 (100, [M—OCH2CO2H]+); 266 (12, [M+1]+); 284 (58, [M+18]+);
-
- Procedure
- 510 mg (2.47 mmol, 1 eq) of DCC in solution in 20 ml of THF are added at 0° C. to a solution of 650 mg (2.44 mmol, 1 eq) of (anthracen-9-ylmethoxy)
acetic acid 1 and 300 mg of NHS (2.61 mmol, 1.07 eq) in 30 ml of THF. The mixture is stirred overnight at room temperature. The reaction medium is then filtered and then evaporated. The residue obtained is taken up in 50 ml of absolute ethanol in order to give after filtration 727 mg of 2,5-dioxopyrrolidin-1-yle (anthracen-9-ylmethoxy)acetate 2 in the form of a white solid (yield: 82%). - EF: C21H17NO5 m.p.: 363.374 g/mol
- TLC: Rf (EtOAc/Hex; 50/50): 0.33;
-
-
- MS (70 eV/DCI/intensity %): m/e: 381 (100, [M+18]+);
-
- Procedure
- 1.75 ml of TEA and 91 mg (0.25 mmol, 1 eq) of 2,5-dioxopyrrolidin-1-yl (anthracen-9-ylmethoxy) acetate 2 in solution in 5 ml of CH2Cl2 are added to a solution of 370 mg (2.50 mmol, 10 eq) of 2,2′-(ethylenedioxy)diethylamine in 20 ml of CH2Cl2. The mixture is stirred for 7 hours at room temperature. The reaction medium is then evaporated. The residue obtained is washed with 50 ml of water and then 50 ml of an aqueous potassium hydroxide solution (0.1 N). The organic phase is dried, evaporated and concentrated under vacuum to give after chromatography on silica (CH2Cl2/MeOH/TEA; 90/10/1), 55 mg of N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-2-(anthracen-9-ylmethoxy)acetamide 3 in the form of a yellow oil (yield: 55%).
- EF: C23H28N2O4 m.p.: 396.491 g/mol
- TLC: Rf (CH2Cl2/MeOH/TEA; 90/10/1): 0.28;
-
-
- MS (70 eV/DCI/intensity %): m/e: 397 (100, [M+1]+);
-
- Procedure
- 1 ml of TEA and 40 mg (0.12 mmol, 1.2 eq) of biotin-NHS in solution in 5 ml of DMF are added to a solution of 40 mg (0.1 mmol, 1 eq) of N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-2-(anthracen-9-ylmethoxy)acetamide 3 in 5 ml of DMF. The mixture is stirred for 16 hours at room temperature. The reaction medium is concentrated under vacuum in order to give after chromatography on silica (CH2Cl2/MeOH/TEA; 95/5/1), 55 mg of N-{2-[2-(2-(aminobiotin)ethoxy)ethoxy]ethyl}-2-(anthracen-9-ylmethoxy)acetamide 4 in the form of a yellow oil (yield: 89%).
- EF: C33H42N4O6S m.p.: 622.793 g/mol
- TLC: Rf (CH2Cl2/MeOH; 90/10): 0.5;
-
-
- MS (70 eV/DCI/intensity %): m/e: 623 (100, [M+1]+); 640 (8, [M+18]+);
- Protocol: 1 to 20 μl of a solution of chemical reagent called CR174 and whose chemical formula is illustrated below, (1 mg/ml) in methanol are added to 20 μl of a solution of nanotubes of carbon (10 mg/ml in methanol), freshly sonicated. The mixture is then stirred by sonication and then evaporated to dryness by a stream of ethane gas. 40 μl of Tris buffer (20 mM, pH 7.5; 50 mM NaCl) are added to the dry nanotubes of carbon and the suspension is remixed by sonication. The suspension may be optionally centrifuged and washed several times with 500 μl of buffer in order to remove the excess reagent not adsorbed on the nanotubes of carbon.
- The physical adsorption of the reagent CR174 on the nanotubes of carbon was able to be demonstrated by electron microscopy with positive staining. The presence of molecules of reagents on the nanotubes of carbon results in the appearance of black spots. These black spots are absent in the absence of the chemical reagent CR174 (or 5).
- As is evident from the preceding text, the invention is not at all limited to its embodiments, implementations and applications which have just been described more explicitly; on the contrary, it encompasses all the variants which may occur to a specialist in this field, without departing from the framework or the scope of the present invention.
Claims (13)
1. Method for the attachment and self-organization of biological macromolecules, characterized in that it comprises the incubation, without stirring, for at least 15 minutes, of a biological macromolecule in solution with nanotubes of carbon closed at their ends, under suitable temperature and pH conditions.
2. Method according to claim 1 , characterized in that the said biological macromolecules are in particular soluble, membrane or transmembrane proteins, enzymes, antibodies, antibody fragments or nucleic acids.
3. Method according to claim 1 or claim 2 , characterized in that the aid nanotubes of carbon are functionalized by physical adsorption, at their surface, of a chemical reagent of general formula H—E—L,
in which:
H represents a hydrophilic group selected from the positively or negatively charged groups; ligands or analogues of biological macromolecules; organometallic complexes interacting with amino acids or nucleic acids and whose ligands are optionally functionalized with alkyl groups for bonding to E;
E represents a spacer arm, selected from C1-C10 carbon chains, optionally substituted with alkyl groups, having unsaturations or otherwise or polyoxyethylene units which may have or otherwise in the middle of the chain phosphate groups, such as:
in which:
m represents an integer from 1 to 10,
X represents O, NHCO, OCO, COO, CONH, S, CH2 or NH and constitutes, at the ends of the said carbon chains, organic functions for adhesion of the ester, amide, ether or thioether type;
L represents a lipid unit with one or more chains of variable length, in the form of C12-C20 having unsaturations or otherwise; an aromatic group of formula Ar1 or of formula Ar2:
in which:
A represents a hydrogen atom, one of the following groups: alkyl, CF3, NO2, NH2, OH, O-alkyl, S-alkyl, COOH, halogen, an aromatic ring or an aromatic heterocycle in the form of C4-C6, optionally polysubstituted with electron-donating groups of the alkyl type or electron-attracting groups of the CF3 or halide type; and
Y represents a bond with E.
4. Method according to any one of claims 1 to 3 , characterized in that the said solution consists of a solvent for solubilizing the said biological macromolecules, which is aqueous or aqueous-alcoholic and which optionally contains at least one detergent.
5. Method according to any one of claims 1 to 4 , characterized in that the incubation conditions are preferably the following: incubation at room temperature, for 15 minutes to 48 hours, at a pH of between 5.5 and 8.5.
6. Bionanomaterials, characterized in that they consist of nanotubes of carbon, on which biological macromolecules are self-organized in a crystalline form.
7. Bionanomaterials according to claim 6 , characterized in that they are obtained with the aid of a method according to any one of claims 1 to 5 .
8. Use of the bionanomaterials according to either of claims 6 and 7, for the structural study of the biological macromolecules which are associated with them.
9. Use of the bionanomaterials according to either of claims 6 and 7, as biological reagent.
10. Use of the bionanomaterials according to either of claims 6 and 7, as biosensors or bioconductors.
11. Chemical reagent capable of being physically adsorbed on nanotubes of carbon, characterized in that it has the general formula H—E—L, in which:
H represents a hydrophilic group selected from the positively or negatively charged groups; ligands or analogues of biological macromolecules; organometallic complexes interacting with amino acids or nucleic acids and whose ligands are optionally functionalized with alkyl groups for bonding to E;
E represents a spacer arm, selected from C1-C10 carbon chains, optionally substituted with alkyl groups, having unsaturations or otherwise or polyoxyethylene units which may have or otherwise in the middle of the chain phosphate groups, such as:
in which:
m represents an integer from 1 to 10,
X represents O, NHCO, OCO, COO, CONH, S, CH2 or NH and constitutes, at the ends of the said carbon chains, organic functions for adhesion of the ester, amide, ether or thioether type;
L represents an aromatic group of formula Ar1 or of formula Ar2:
in which:
A represents a hydrogen atom, one of the following groups: alkyl, CF3, NO2, NH2, OH, O-alkyl, S-alkyl, COOH, halogen, an aromatic ring or an aromatic heterocycle in the form of C4-C6, the said rings being optionally polysubstituted with electron-donating groups of the alkyl type or electron-attracting groups of the CF3 or halide type; and
Y represents a bond with E.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/618,586 US20040018543A1 (en) | 1998-05-07 | 2003-07-15 | Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98401114 | 1998-05-07 | ||
EP98401114.8 | 1998-05-07 | ||
FR9806539A FR2778846B1 (en) | 1998-05-25 | 1998-05-25 | METHOD FOR FIXING AND / OR CRYSTALLIZING BIOLOGICAL MACROMOLECULES ON CARBON NANOTUBES AND ITS APPLICATIONS |
FR98/06539 | 1998-05-25 | ||
US09/673,668 US6656712B1 (en) | 1998-05-07 | 1999-05-07 | Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses |
US10/618,586 US20040018543A1 (en) | 1998-05-07 | 2003-07-15 | Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/673,668 Division US6656712B1 (en) | 1998-05-07 | 1999-05-07 | Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses |
PCT/FR1999/001086 Division WO1999057564A1 (en) | 1998-05-07 | 1999-05-07 | Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040018543A1 true US20040018543A1 (en) | 2004-01-29 |
Family
ID=26151633
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/673,668 Expired - Fee Related US6656712B1 (en) | 1998-05-07 | 1999-05-07 | Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses |
US10/618,586 Abandoned US20040018543A1 (en) | 1998-05-07 | 2003-07-15 | Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/673,668 Expired - Fee Related US6656712B1 (en) | 1998-05-07 | 1999-05-07 | Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses |
Country Status (6)
Country | Link |
---|---|
US (2) | US6656712B1 (en) |
EP (1) | EP1078261B1 (en) |
JP (1) | JP4484361B2 (en) |
AU (1) | AU3529299A (en) |
DE (1) | DE69921472T2 (en) |
WO (1) | WO1999057564A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005104179A2 (en) * | 2004-04-27 | 2005-11-03 | Koninklijke Philips Electronics N.V. | Use of carbon nanotubes (cnts) for analysis of samples |
US20060041104A1 (en) * | 2004-08-18 | 2006-02-23 | Zyvex Corporation | Polymers for enhanced solubility of nanomaterials, compositions and methods therefor |
US20060054866A1 (en) * | 2004-04-13 | 2006-03-16 | Zyvex Corporation. | Methods for the synthesis of modular poly(phenyleneethynlenes) and fine tuning the electronic properties thereof for the functionalization of nanomaterials |
US20070018045A1 (en) * | 2005-06-10 | 2007-01-25 | Callahan Kevin S | Method of attaching electrically powered seat track cover to through hole seat track design |
US20070265379A1 (en) * | 2003-05-22 | 2007-11-15 | Zyvex Corporation | Nanocomposites and methods thereto |
US20080194737A1 (en) * | 2002-05-02 | 2008-08-14 | Zyvex Performance Materials, Llc | Polymer and method for using the polymer for solubilizing nanotubes |
WO2013039819A2 (en) * | 2011-09-12 | 2013-03-21 | Nanoselect, Inc. | Layer-by-layer carbon nanostructure surface functionalization and devices |
US20150185237A1 (en) * | 2012-05-23 | 2015-07-02 | University Of Calcutta | Molecular discriminators using carbon nanotubes |
WO2015150775A1 (en) * | 2014-03-31 | 2015-10-08 | Imperial Innovations Limited | Nucleant for macromolecule crystallisation |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2778918B1 (en) * | 1998-05-25 | 2000-07-21 | Commissariat Energie Atomique | MOLECULAR STICK AND ITS APPLICATIONS |
US8029734B2 (en) * | 2001-03-29 | 2011-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | Noncovalent sidewall functionalization of carbon nanotubes |
US20040132070A1 (en) * | 2002-01-16 | 2004-07-08 | Nanomix, Inc. | Nonotube-based electronic detection of biological molecules |
US8154093B2 (en) | 2002-01-16 | 2012-04-10 | Nanomix, Inc. | Nano-electronic sensors for chemical and biological analytes, including capacitance and bio-membrane devices |
TW200307563A (en) * | 2002-02-14 | 2003-12-16 | Sixty Inc C | Use of BUCKYSOME or carbon nanotube for drug delivery |
US7547931B2 (en) * | 2003-09-05 | 2009-06-16 | Nanomix, Inc. | Nanoelectronic capnometer adaptor including a nanoelectric sensor selectively sensitive to at least one gaseous constituent of exhaled breath |
US7522040B2 (en) * | 2004-04-20 | 2009-04-21 | Nanomix, Inc. | Remotely communicating, battery-powered nanostructure sensor devices |
US20070048180A1 (en) * | 2002-09-05 | 2007-03-01 | Gabriel Jean-Christophe P | Nanoelectronic breath analyzer and asthma monitor |
US7304128B2 (en) * | 2002-06-04 | 2007-12-04 | E.I. Du Pont De Nemours And Company | Carbon nanotube binding peptides |
US7948041B2 (en) | 2005-05-19 | 2011-05-24 | Nanomix, Inc. | Sensor having a thin-film inhibition layer |
US20060263255A1 (en) * | 2002-09-04 | 2006-11-23 | Tzong-Ru Han | Nanoelectronic sensor system and hydrogen-sensitive functionalization |
US20070114573A1 (en) * | 2002-09-04 | 2007-05-24 | Tzong-Ru Han | Sensor device with heated nanostructure |
AU2003299538B2 (en) * | 2002-09-20 | 2008-05-15 | The Trustees Of Boston College | Nanotube cantilever probes for nanoscale magnetic microscopy |
US7214303B2 (en) * | 2002-09-20 | 2007-05-08 | The Trustees Of Boston College | Cantilever probes for nanoscale magnetic and atomic force microscopy |
FR2853657B1 (en) | 2003-04-10 | 2005-06-24 | Centre Nat Rech Scient | AUTO-ASSEMBLED AND PHOTOPOLYMERIZED MACROMOLECULES AROUND CARBON NANOTUBES, PROCESS FOR THEIR PREPARATION, AND APPLICATIONS THEREOF |
US20060199770A1 (en) * | 2003-04-14 | 2006-09-07 | Alberto Bianco | Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
KR100525764B1 (en) * | 2003-06-13 | 2005-11-04 | 한국과학기술원 | Biosensor using the conductive carbon nanotubes and method thereof |
DE10345157B4 (en) * | 2003-09-29 | 2009-01-08 | Qimonda Ag | Thermally conductive packaging of electronic circuit units |
US7399400B2 (en) * | 2003-09-30 | 2008-07-15 | Nano-Proprietary, Inc. | Nanobiosensor and carbon nanotube thin film transistors |
US20050147964A1 (en) * | 2003-12-30 | 2005-07-07 | Intel Corporation | Methods for identifying a peptide that binds a geometrical shape |
US9062392B2 (en) | 2003-12-30 | 2015-06-23 | Intel Corporation | Methods for isolating a peptide methods for identifying a peptide |
EP1605265A1 (en) | 2004-06-09 | 2005-12-14 | Centre National De La Recherche Scientifique (Cnrs) | Non-covalent complexes comprising carbon nanotubes |
WO2007013872A2 (en) | 2004-07-22 | 2007-02-01 | The Board Of Trustees Of The University Of Illinois | Sensors employing single-walled carbon nanotubes |
KR100779008B1 (en) * | 2005-11-16 | 2007-11-28 | 광주과학기술원 | Ph-sensitive luminescent single-wall carbon nanotube derivative and preparation thereof |
US8859048B2 (en) * | 2006-01-03 | 2014-10-14 | International Business Machines Corporation | Selective placement of carbon nanotubes through functionalization |
KR100699244B1 (en) | 2006-01-10 | 2007-03-28 | 이상훈 | High Efficiency Micro Reaction Block and Manufacturing Method Thereof |
WO2007089550A2 (en) * | 2006-01-26 | 2007-08-09 | Nanoselect, Inc. | Cnt-based sensors: devices, processes and uses thereof |
US20090278556A1 (en) * | 2006-01-26 | 2009-11-12 | Nanoselect, Inc. | Carbon Nanostructure Electrode Based Sensors: Devices, Processes and Uses Thereof |
JP4953072B2 (en) * | 2007-04-11 | 2012-06-13 | 独立行政法人物質・材料研究機構 | Bioreactive carbon nanotubes functionalized by non-covalent bonding of redox proteins |
KR20080106102A (en) * | 2007-05-30 | 2008-12-04 | 주식회사 엘지화학 | Dispersant containing metal complex for carbon nanotube |
WO2010123534A2 (en) * | 2009-01-16 | 2010-10-28 | Rensselaer Polytechnic Institute | Enzyme-based nanoscale decontaminating composites |
US8993346B2 (en) * | 2009-08-07 | 2015-03-31 | Nanomix, Inc. | Magnetic carbon nanotube based biodetection |
JP6516248B2 (en) * | 2014-12-08 | 2019-05-22 | 国立大学法人福井大学 | Method for immobilizing biomolecules having molecular recognition function to conductive carbon material |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866434A (en) * | 1994-12-08 | 1999-02-02 | Meso Scale Technology | Graphitic nanotubes in luminescence assays |
US6403705B1 (en) * | 1998-05-25 | 2002-06-11 | Commissariat A L'energie Atomique | Molecular rod and uses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2200562C2 (en) * | 1996-03-06 | 2003-03-20 | Хайперион Каталайзис Интернэшнл, Инк. | Functionalized nanotubes |
-
1999
- 1999-05-07 DE DE69921472T patent/DE69921472T2/en not_active Expired - Lifetime
- 1999-05-07 EP EP99917007A patent/EP1078261B1/en not_active Expired - Lifetime
- 1999-05-07 US US09/673,668 patent/US6656712B1/en not_active Expired - Fee Related
- 1999-05-07 AU AU35292/99A patent/AU3529299A/en not_active Abandoned
- 1999-05-07 JP JP2000547479A patent/JP4484361B2/en not_active Expired - Fee Related
- 1999-05-07 WO PCT/FR1999/001086 patent/WO1999057564A1/en active IP Right Grant
-
2003
- 2003-07-15 US US10/618,586 patent/US20040018543A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866434A (en) * | 1994-12-08 | 1999-02-02 | Meso Scale Technology | Graphitic nanotubes in luminescence assays |
US6403705B1 (en) * | 1998-05-25 | 2002-06-11 | Commissariat A L'energie Atomique | Molecular rod and uses |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080194737A1 (en) * | 2002-05-02 | 2008-08-14 | Zyvex Performance Materials, Llc | Polymer and method for using the polymer for solubilizing nanotubes |
US20070265379A1 (en) * | 2003-05-22 | 2007-11-15 | Zyvex Corporation | Nanocomposites and methods thereto |
US20090203867A1 (en) * | 2004-04-13 | 2009-08-13 | Zyvex Performance Materials, Inc. | Methods for the synthesis of modular poly(phenyleneethynylenes) and fine tuning the electronic properties thereof for the functionalization of nanomaterials |
US20060054866A1 (en) * | 2004-04-13 | 2006-03-16 | Zyvex Corporation. | Methods for the synthesis of modular poly(phenyleneethynlenes) and fine tuning the electronic properties thereof for the functionalization of nanomaterials |
WO2005104179A3 (en) * | 2004-04-27 | 2006-08-31 | Koninkl Philips Electronics Nv | Use of carbon nanotubes (cnts) for analysis of samples |
WO2005104179A2 (en) * | 2004-04-27 | 2005-11-03 | Koninklijke Philips Electronics N.V. | Use of carbon nanotubes (cnts) for analysis of samples |
US20090166523A1 (en) * | 2004-04-27 | 2009-07-02 | Koninklijke Philips Electronic, N.V. | Use of carbon nanotubes (cnts) for analysis of samples |
US20060041104A1 (en) * | 2004-08-18 | 2006-02-23 | Zyvex Corporation | Polymers for enhanced solubility of nanomaterials, compositions and methods therefor |
US20070018045A1 (en) * | 2005-06-10 | 2007-01-25 | Callahan Kevin S | Method of attaching electrically powered seat track cover to through hole seat track design |
WO2013039819A2 (en) * | 2011-09-12 | 2013-03-21 | Nanoselect, Inc. | Layer-by-layer carbon nanostructure surface functionalization and devices |
WO2013039819A3 (en) * | 2011-09-12 | 2013-05-10 | Nanoselect, Inc. | Layer-by-layer carbon nanostructure surface functionalization and devices |
US20150185237A1 (en) * | 2012-05-23 | 2015-07-02 | University Of Calcutta | Molecular discriminators using carbon nanotubes |
US9817002B2 (en) * | 2012-05-23 | 2017-11-14 | University Of Calcutta | Molecular discriminators using carbon nanotubes |
WO2015150775A1 (en) * | 2014-03-31 | 2015-10-08 | Imperial Innovations Limited | Nucleant for macromolecule crystallisation |
Also Published As
Publication number | Publication date |
---|---|
US6656712B1 (en) | 2003-12-02 |
JP4484361B2 (en) | 2010-06-16 |
EP1078261B1 (en) | 2004-10-27 |
AU3529299A (en) | 1999-11-23 |
JP2002513815A (en) | 2002-05-14 |
WO1999057564A1 (en) | 1999-11-11 |
EP1078261A1 (en) | 2001-02-28 |
DE69921472D1 (en) | 2004-12-02 |
DE69921472T2 (en) | 2006-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6656712B1 (en) | Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses | |
RU2200562C2 (en) | Functionalized nanotubes | |
EP2076463B1 (en) | Complexes of carbon nanotubes and fullerences with molecular-clips and use thereof | |
US7052861B2 (en) | Graphitic nanotubes in luminescence assays | |
US5510481A (en) | Self-assembled molecular films incorporating a ligand | |
US20040202603A1 (en) | Functionalized nanotubes | |
Yamamoto et al. | High-speed atomic force microscopy techniques for observing dynamic biomolecular processes | |
US20060246482A1 (en) | Linker molecules for selective metallisation of nucleic acids and their uses | |
JP2008513318A (en) | Functionalized single-walled carbon nanotubes | |
WO2003090255A2 (en) | Encapsulation of nanotubes via self-assembled nanostructures | |
WO2004013605A2 (en) | Nanoparticles comprising a mixed monolayer for specific ligand binding | |
US7449445B2 (en) | Conductive peptide nanofiber and method of manufacture of the same | |
KR100680132B1 (en) | Method for Carbon Nanotubes Array Using Magnetic Material | |
JP3664401B2 (en) | N-glycoside type glycolipid and hollow fiber organic nanotube comprising the same | |
US20060003401A1 (en) | Method for preparing a water-soluble carbon nanotube wrapped with self-assembly materials | |
US6403705B1 (en) | Molecular rod and uses | |
JP2003277397A (en) | Functional peptide fiber, method of producing the same and recovery of peptide chain | |
Loukanov et al. | Biotinylated vanadium and chromium sulfide nanoparticles as probes for colocalization of membrane proteins | |
Ingrosso et al. | Surface chemical functionalization of single walled carbon nanotubes with a bacteriorhodopsin mutant | |
FR2778846A1 (en) | Crystallization of biological macromolecules on carbon nanotubes | |
US20130123466A1 (en) | Simultaneous synthesis of temperature-tunable peptide and gold nanoparticle hybrid spheres | |
KR101578994B1 (en) | Carbon Nanotube-Antibody Conjugate and Detection of Target Substances Using the same | |
KR101227690B1 (en) | Preparation and application of graphene oxide/mwcnt film-based substrate for ldi-ms | |
KR100866325B1 (en) | Probe for signal detection and electron emission, and method of manufacturing for same | |
JP2006513985A (en) | Fiber shaping peptide capable of interacting with self-assembling peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |